Mechanisms of resistance to apoptosis linked to SLs have also been explored in PBMCs isolated from CLL patients, and it was found that resistance to standard therapies (such as fludarabine, rituximab, and cyclophosphamide) was associated with an upregulation of GCS and decreased levels of ceramide [288]. This evidence concerns the gene UGCG and B-cell chronic lymphocytic leukemia.